Ketamine for Anxiety
Find clinics offering ketamine therapy for anxiety disorders.
Editorially checked against cited literature and FDA information; not reviewed by a named clinician · Last checked July 2026
💡 Ketamine Therapy for Anxiety: What You Need to Know
Anxiety disorders are commonly treated with psychotherapy and established medications. Ketamine is being researched for some anxiety disorders, but it is not FDA-approved for anxiety and the available studies are smaller and less conclusive than the evidence for standard treatments.
Potential benefits, adverse effects, misuse risk, interactions, and uncertainty about long-term outcomes should be discussed with a qualified clinician. A clinic offering ketamine does not establish that it is appropriate or evidence-based for a particular patient or anxiety diagnosis.
How Ketamine Works for Anxiety
Ketamine reduces anxiety through its modulation of the glutamate system, the brain's primary excitatory neurotransmitter network. In anxiety disorders, the amygdala — the brain's fear center — is hyperactive, generating excessive fear and worry signals. Ketamine helps reduce this amygdala hyperactivity by rebalancing glutamate signaling and promoting new, healthier neural connections in the prefrontal cortex, which is responsible for regulating emotional responses.
Additionally, ketamine has GABAergic properties that provide direct anxiolytic (anti-anxiety) effects. This dual mechanism — calming the overactive fear response while simultaneously strengthening the brain's ability to regulate emotions — makes ketamine uniquely effective for anxiety. The dissociative experience during treatment may also help patients gain psychological distance from their anxious thought patterns, which can enhance the therapeutic benefit when combined with psychotherapy.
Clinical Evidence
Multiple randomized controlled trials have demonstrated ketamine's anxiolytic effects. A key study by Glue et al. (2017) showed dose-dependent reductions in anxiety symptoms following ketamine administration, with higher sub-anesthetic doses producing greater anxiety relief. Research in patients with comorbid depression and anxiety has consistently shown that ketamine improves both conditions simultaneously, with anxiety response rates comparable to those seen in depression treatment. A 2020 systematic review found that the majority of studies reported significant anxiety reduction within hours of ketamine administration.
Who Is a Candidate?
Good candidates for ketamine therapy for anxiety include patients who have tried and failed to respond to first-line treatments such as SSRIs (sertraline, escitalopram), SNRIs (venlafaxine, duloxetine), and psychotherapy approaches like CBT. Patients with comorbid depression and anxiety are particularly strong candidates, as ketamine has been shown to improve both conditions simultaneously. Those seeking to reduce dependence on benzodiazepines or those who experience intolerable side effects from traditional anxiety medications may also benefit from ketamine treatment.
Side Effects to Consider
Common side effects during ketamine treatment for anxiety include temporary dissociation, lightheadedness, nausea, and mild increases in blood pressure and heart rate. Some patients may experience a brief intensification of anxiety during the onset of the infusion before the anxiolytic effects take hold. These side effects are transient, typically resolving within 1-2 hours after treatment. Patients are monitored throughout the infusion and for a recovery period afterward. Paradoxical anxiety during treatment is rare but can occur and is managed by adjusting the infusion rate.
Frequently Asked Questions
Common questions about ketamine therapy for anxiety disorders.
Can ketamine help with anxiety?
Ketamine is being studied for anxiety disorders, but it is not FDA-approved for this use and the evidence is less established than for approved first-line treatments. Small studies cannot predict an individual response or establish long-term safety. A qualified clinician should review standard treatments, contraindications, potential adverse effects, and the limits of current evidence before any off-label use.
How does ketamine reduce anxiety?
Ketamine reduces anxiety through a dual mechanism that targets the root neurological drivers of anxiety disorders. First, it modulates glutamate neurotransmission to calm the overactive amygdala — the brain's fear center that generates excessive worry and threat signals in anxiety patients — while simultaneously strengthening prefrontal cortex function, which is responsible for regulating emotional responses. Second, ketamine has GABAergic properties that provide direct anxiolytic effects, similar to how benzodiazepines work but without the associated risks of physical dependence and tolerance. A 2020 systematic review found that the majority of clinical studies reported significant anxiety reduction within hours of ketamine administration, a speed unmatched by conventional anxiety medications. Additionally, the neuroplasticity ketamine promotes through BDNF production helps build new, healthier neural pathways that can provide lasting anxiety relief beyond the immediate treatment session. Ask your provider whether standalone infusions or ketamine-assisted psychotherapy would better address your specific anxiety pattern.
Is ketamine FDA approved for anxiety?
Ketamine is not currently FDA-approved specifically for anxiety disorders. However, it is legally used off-label for anxiety by licensed physicians, which is a common and accepted practice in medicine — an estimated 20% of all prescriptions in the United States are written for off-label uses. Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression, and many patients with comorbid anxiety and depression experience meaningful improvement in both conditions simultaneously during ketamine treatment. Multiple randomized controlled trials have demonstrated ketamine's anxiolytic effects, including research in generalized anxiety disorder, social anxiety disorder, and mixed anxiety-depression presentations. While the lack of a specific FDA indication for anxiety means insurance is unlikely to cover ketamine for an anxiety-only diagnosis, patients with co-occurring depression and anxiety may have more coverage options through Spravato. Discuss your full symptom profile with your psychiatrist to determine the most appropriate treatment pathway and potential insurance eligibility.
How many ketamine sessions are needed for anxiety?
A typical initial course of ketamine for anxiety consists of six infusions administered over 2–3 weeks, following the same protocol used for treatment-resistant depression. Many patients begin to notice anxiety reduction after the first or second session, with maximum benefit often achieved by the end of the initial series as cumulative neuroplasticity effects strengthen prefrontal cortex regulation of the fear response. Maintenance treatments are usually needed every 3–8 weeks to sustain the benefits, with the specific frequency determined by your individual response pattern. Research by Glue et al. (2017) demonstrated dose-dependent anxiety relief, so your clinician may also adjust the ketamine dose across sessions to optimize your outcome. Some patients find that combining ketamine with ongoing cognitive behavioral therapy or other psychotherapy extends the duration of relief between maintenance sessions. Track your anxiety levels between treatments using a standardized measure like the GAD-7 so your provider can fine-tune your long-term treatment schedule.
References
- Glue P et al. (2017) J Psychopharmacol. Ascending-dose study showed ketamine produced dose-related reductions in anxiety symptoms in patients with treatment-refractory anxiety disorders. [DOI]
- Taylor JH et al. (2018) Neuropsychopharmacology. Randomized placebo-controlled crossover trial found a single ketamine infusion significantly reduced social anxiety disorder symptoms. [DOI]
- Tully JL et al. (2022) Br J Clin Pharmacol. Systematic review found ketamine showed promising anxiolytic effects across multiple anxiety disorders, though larger trials are needed. [DOI]
Treatment Types for Anxiety
Explore the different ways ketamine therapy can be administered for anxiety disorders.
IV Ketamine Infusion
Intravenous delivery. Fastest onset, 60-70% response rate. $400-800/session.
Spravato (Esketamine)
FDA-approved nasal spray. Often insurance-covered. $590-885/session.
IM Injection
Intramuscular injection. Similar efficacy, lower cost. $250-500/session.
KAP (Ketamine-Assisted Psychotherapy)
Combines ketamine with guided psychotherapy. $500-1,500/session.